MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer Research

MC0704 is a STAT3 inhibitor (IC50=2.13 μM), which can be used for the research of metastatic triple-negative breast cancer (mTNBC).

Navitoclax (ABT-263) is an Orally Active Bcl-2 Inhibitor for

Izalontamab (SI-B001) is a Bispecific Anti-EGFR/HER3 mAb for

NG25, a Dual Inhibitor of TAK1 and MAP4K2, Enhances Doxorubicin-mediated Apoptosis in Breast Cancer

EW-7195 is a Specific ALK5 (TGFβR1) Inhibitor with Anti-Metastasis Activity

KGP94 is a Selective Inhibitor of Cathepsin L for Cancer Research

PND-1186 is a Highly-Specific FAK Inhibitor and Induces Apoptosis

Relationship between signal transducer and activator of

TK4g is a JAK Inhibitor for Leukemia Cancer Research

CX-5461 is an Orally Active rRNA Synthesis Inhibitor

GN25 is a Specific p53-Snail Binding Inhibitor with Antitumor Effects

Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated

CYD-2-11 is a Selective Bax Agonist for Breast and Lung Cancer Research

Triple-Negative Breast Cancer - Network of Cancer Research